T Cell Therapies | Adriana Rossi, MD | TANDEM 2022
Interview with Adriana Rossi, MD at TANDEM 2022. Filmed April 25th 2022.
The Myeloma Crowd brings information from the experts to the patients! Learn more at https://www.myelomacrowd.org/
HealthTree Cure Hub helps you find your best treatment options and accelerate a cure for multiple myeloma. Join today at https://www.healthtree.org/
Follow Myeloma Crowd:
Twitter: www.twitter.com/myelomacrowd
Facebook: www.facebook.com/myelomacrowd
Instagram: www.instagram.com/myelomacrowd
Видео T Cell Therapies | Adriana Rossi, MD | TANDEM 2022 канала HealthTree Foundation for Multiple Myeloma
The Myeloma Crowd brings information from the experts to the patients! Learn more at https://www.myelomacrowd.org/
HealthTree Cure Hub helps you find your best treatment options and accelerate a cure for multiple myeloma. Join today at https://www.healthtree.org/
Follow Myeloma Crowd:
Twitter: www.twitter.com/myelomacrowd
Facebook: www.facebook.com/myelomacrowd
Instagram: www.instagram.com/myelomacrowd
Видео T Cell Therapies | Adriana Rossi, MD | TANDEM 2022 канала HealthTree Foundation for Multiple Myeloma
Показать
Комментарии отсутствуют
Информация о видео
27 апреля 2022 г. 16:00:07
00:01:56
Другие видео канала
![Round Table Audience Q&A Two | RT Irvine, CA Nov 5, 2022](https://i.ytimg.com/vi/J1B5MuU1_t0/default.jpg)
![CELMoDs® Mezigdomide | Paul Richardson, MD | IMS 2022](https://i.ytimg.com/vi/i_hn7jiwJjo/default.jpg)
![The HealthTree Foundation 10 Year Anniversary](https://i.ytimg.com/vi/yFw06QnBIls/default.jpg)
![Medicare 101 for Myeloma Patients: What You Need to Know for 2023](https://i.ytimg.com/vi/f1KQPIOBRo4/default.jpg)
![MCRT Baltimore 2018: Immunotherapy for Multiple Myeloma by Ivan Borrello, MD](https://i.ytimg.com/vi/CaFqPRGEe3Y/default.jpg)
![ASH 2019: New Drugs Targeting BCMA — Immunotherapy for Myeloma | Dr. Gareth Morgan](https://i.ytimg.com/vi/mRnjTrFpSeA/default.jpg)
![Exciting Advances in Myeloma Treatment | Timothy Schmidt, MD | ASCO 2023](https://i.ytimg.com/vi/eSyF8IXp77U/default.jpg)
![HealthTree University: Free Myeloma Education for All](https://i.ytimg.com/vi/A6U2ChxjtuM/default.jpg)
![ImmunoPET- an Advanced Companion to MRD Testing](https://i.ytimg.com/vi/1ut5abb27Oo/default.jpg)
![Health Disparities Related to CAR-T Therapy in Myeloma | Samer Al Hadidi, MD | ASH 2021](https://i.ytimg.com/vi/TLaY3cRCXnA/default.jpg)
![First-line Vs. Second-Line Treatment | Matthew LeBlanc, PhD | IMS 2022](https://i.ytimg.com/vi/7PnS63MpePY/default.jpg)
![MASTER Trial Update: MRD based response adaptive therapy | Luciano Costa, MD, PhD | ASH 2021](https://i.ytimg.com/vi/XwuMkv8LqU8/default.jpg)
![Quad Therapies and Side Effects | Nathan Sweeney, PhD | ASH 2022](https://i.ytimg.com/vi/JTqQCn2FHiI/default.jpg)
![Saad Usmani, MD: How Do We Assess Multiple Myeloma Response in 2018? MCRT Charlotte 2018](https://i.ytimg.com/vi/gdlkX5JGEDQ/default.jpg)
![iSTOPMM study and early MGUS and SMM screening | Joshua Richter, MD | ASH 2021](https://i.ytimg.com/vi/mUA_n84ERWI/default.jpg)
![MCRT San Diego 2020: Myeloma Expert Panel – Q&A Afternoon Session](https://i.ytimg.com/vi/WXPE2lEypnY/default.jpg)
![Clinical Trial: INSIGHT Trial by Takeda Oncology](https://i.ytimg.com/vi/mfClvrgbxZk/default.jpg)
![Benjamin Derman, MD | MCRT Chicago, Illinois April 30, 2022](https://i.ytimg.com/vi/quT0Z9miSag/default.jpg)
![ASCO/EHA 2024 Myeloma Highlights | Ajai Chari, MD | EHA 2024](https://i.ytimg.com/vi/vyjNEnt_3fs/default.jpg)
![Vaccinations & iStopMM Trial | Natalie Callander, MD | IMS 2022](https://i.ytimg.com/vi/ZEawHiMA-jI/default.jpg)
![Taking Your Fitness Routine to the Next Level](https://i.ytimg.com/vi/L1Qbb3eQMtU/default.jpg)